IP Library Assignment 025981/0068
Patent Assignment
Reel/Frame 025981/0068

Security Agreement

Recorded: 2011-03-18 Pages: 10
Assignor
DRUGTECH CORPORATION
Executed: 2011-03-17
Assignee
WILMINGTON TRUST FSB (AS COLLATERAL AGENT)
50 SOUTH SIXTH STREET, SUITE 1290, MINNEAPOLIS, MINNESOTA, 55402-1544
Covered Properties (48)
Dosage Form and Method of Use
Anti-Proliferative Combinations
Oral Once-Per-Day Formulation Which Does Not Induce Tolerance
Patent: 5,296,232 →
Application: 07/882,537 →
Extended Release Pharmaceutical Formulations
Patent: 5,445,829 →
Application: 07/898,539 →
Long Acting Gi and Esophageal Protectant
Patent: 5,554,379 →
Application: 08/262,254 →
Multi-Vitamin and Mineral Supplement for Pregnant Women
Patent: 5,494,678 →
Application: 08/410,733 →
Long Acting Gi and Esophageal Protectant
Patent: 5,670,163 →
Application: 08/432,805 →
Bioadhesive Pharmaceutical Delivery System
Patent: 5,554,380 →
Application: 08/441,297 →
Multi-Vitamin and Mineral Supplements for Women
Patent: 5,869,084 →
Application: 08/474,071 →
Multi- Vitamin and Mineral Supplement for Pregnant Women
Patent: 6,228,388 →
Application: 08/852,600 →
Long Acting Gi and Esophageal Protectant
Patent: 5,858,391 →
Application: 08/864,109 →
Vitamin/Nutrient Dosage Regimentation
Patent: 6,696,083 →
Application: 09/016,786 →
Maximizing Effectiveness of Substances Used to Improve Health and Well Being
Patent: 5,945,123 →
Application: 09/053,487 →
Folic Acid Supplement
Patent: 6,261,600 →
Application: 09/303,000 →
Dietary Supplement
Patent: 6,569,857 →
Application: 09/303,689 →
Anti-Nausea Compositions and Methods
Patent: 6,197,329 →
Application: 09/303,690 →
Maximizing Effectiveness of Substances Used to Improve Health and Well Being
Patent: 6,214,379 →
Application: 09/323,158 →
Nutritional Supplements
Patent: 6,258,846 →
Application: 09/323,159 →
Strip Pack
Patent: 6,375,956 →
Application: 09/358,540 →
Formulation for Menopausal Women
Patent: 6,479,545 →
Application: 09/409,059 →
Multi-Vitamin and Mineral Supplements for Women
Patent: 6,488,956 →
Application: 09/448,744 →
Nutritional Composition
Patent: 6,352,713 →
Application: 09/451,849 →
Composition with Sustained Release of Levodopa and Carbidopa
Patent: 6,531,153 →
Application: 09/866,857 →
Publication: US 2002/0192290
Nutritional Supplements
Patent: 6,576,666 →
Application: 09/885,158 →
Publication: US 2002/0032234
Mineral Supplement
Patent: 6,793,935 →
Application: 10/080,390 →
Publication: US 2002/0119183
Bioadhesive Drug Delivery System
Patent: 6,899,890 →
Application: 10/101,014 →
Publication: US 2003/0180366
Formulation for Menopausal Women
Patent: 7,687,485 →
Application: 10/106,381 →
Publication: US 2002/0137749
Nutritional Supplements
Patent: 7,112,609 →
Application: 10/457,647 →
Publication: US 2003/0216351
Gellan gum based oral controlled release dosage forms-a novel platform technology for gastric retention
Application: 10/565,593 →
Publication: US 2006/0177497
Rapidly Disintegrable Tablets
Patent: 7,282,217 →
Application: 10/929,856 →
Pharmaceutical delivery system
Application: 10/944,416 →
Publication: US 2005/0095245
Composition for topical treatment of mixed vaginal infections
Application: 11/326,979 →
Publication: US 2006/0140990
Therapeutic methods of using estrogen compositions
Application: 11/502,066 →
Publication: US 2008/0085877
Estrogen compositions and therapeutic methods of use thereof
Application: 11/502,253 →
Publication: US 2007/0036848
Delivery System
Patent: 8,057,433 →
Application: 11/571,863 →
Publication: US 2008/0097388
Composition and Method of Use Thereof
Application: 11/617,180 →
Publication: US 2007/0224226
Methods for Determining Absorption of Cobalamin or Analogues Thereof
Patent: 7,727,972 →
Application: 11/658,774 →
Publication: US 2009/0162882
Methods and Compositions for Enhancing Iron Absorption
Application: 11/793,517 →
Publication: US 2009/0028962
Sustained-Release Composition and Method of Use Thereof
Application: 11/850,063 →
Publication: US 2008/0139655
Rapidly Disintegrable Tablets
Patent: 7,425,341 →
Application: 11/853,355 →
Endometriosis Treatment
Application: 12/105,878 →
Publication: US 2008/0287408
Dosage Form and Method of Use
Application: 12/183,989 →
Publication: US 2009/0035370
Compositions Including Iron
Application: 12/195,170 →
Publication: US 2009/0035385
Anti-Proliferative Combinations
Application: 12/199,503 →
Publication: US 2009/0068190
Transdermal, Alcohol-Free, Pharmaceutical Compositions
Application: 12/209,864 →
Publication: US 2009/0098069
Transdermal Hormone Spray
Application: 12/209,961 →
Publication: US 2009/0075963
Nutritional Formulations
Application: 12/578,735 →
Publication: US 2010/0129496
Methods of Administering Compositions Including Iron
Application: 12/891,376 →
Publication: US 2011/0015150
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest Mar 18, 2011
From: U.S. HEALTHCARE I, LLC (AS ADMINISTRATIVE AND COLLATERAL AGENT)
To: DRUGTECH CORPORATION
Reel/Frame 025981/0934 →
Release of Security Interest Mar 18, 2011
From: U.S. HEALTHCARE, LLC (AS ADMINISTRATIVE AND COLLATERAL AGENT)
To: DRUGTECH CORPORATION
Reel/Frame 025980/0024 →
Security Agreement Sep 17, 2013
From: DRUGTECH CORPORATION
To: LAW DEBENTURE TRUST COMPANY OF NEW YORK, AS AGENT
Reel/Frame 031226/0883 →
Change of Name Jul 9, 2014
From: DRUGTECH CORPORATION
To: LUMARA HEALTH IP LTD.
Reel/Frame 033282/0265 →
Assignment of Assignor's Interest Jul 9, 2014
From: HERMELIN, VICTOR M.
To: KV PHARMACEUTICAL COMPANY
Reel/Frame 033269/0393 →
Assignment of Assignor's Interest Jul 9, 2014
From: KV PHARMACEUTICAL COMPANY
To: DRUGTECH CORPORATION
Reel/Frame 033269/0474 →
Assignment of Assignor's Interest Jul 9, 2014
From: HERMELIN, MARC S.; PARADISSIS, GEORGE; GAREGNANI, JAMES A.
To: KV PHARMACEUTICAL COMPANY
Reel/Frame 033269/0500 →
Assignment of Assignor's Interest Jul 9, 2014
From: K-V PHARMACEUTICAL COMPANY
To: DRUGTECH CORPORATION
Reel/Frame 033269/0560 →
Release of Security Interests in Intellectual Property Oct 20, 2014
From: LAW DEBENTURE TRUST COMPANY OF NEW YORK
To: K-V PHARMACEUTICAL COMPANY
Reel/Frame 034018/0040 →
Security Interest Nov 12, 2014
From: LUMARA HEALTH IP LTD
To: JEFFERIES FINANCE LLC
Reel/Frame 034156/0243 →
Security Interest Sep 25, 2015
From: LUMARA HEALTH IP LTD.
To: JEFFERIES FINANCE LLC
Reel/Frame 036653/0138 →
Change of Name Sep 30, 2015
From: DRUGTECH CORPORATION
To: LUMARA HEALTH IP LTD.
Reel/Frame 036725/0894 →
Release of Security Interest Oct 1, 2015
From: WILLMINGTON TRUST, NATIONAL ASSOCIATION
To: LUMARA HEALTH IP LTD
Reel/Frame 036704/0822 →
Release of Security Interest Oct 9, 2015
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: LUMARA HEALTH IP LTD.
Reel/Frame 036763/0475 →
Release of Security Interest May 15, 2017
From: JEFFERIES FINANCE LLC
To: LUMARA HEALTH IP LTD.
Reel/Frame 042461/0626 →
Change of Name Dec 27, 2017
From: LUMARA HEALTH IP LTD.
To: AMAG PHARMACEUTICALS IP, LTD.
Reel/Frame 044961/0232 →
Merger and Change of Name Jan 3, 2018
From: AMAG PHARMACEUTICALS IP, LTD.; AMAG PHARMA USA, INC.
To: AMAG PHARMA USA, INC.
Reel/Frame 044523/0160 →
Assignment of Assignor's Interest Feb 12, 2021
From: AMAG PHARMA USA, INC.
To: COVIS PHARMA GMBH
Reel/Frame 055241/0119 →
Security Interest Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Corrective Assignment to Correct the Receiving Party's Address Previously Recorded at Reel: 055241 Frame: 0119. Assignor(S) Hereby Confirms the Assignment. Feb 23, 2021
From: AMAG PHARMA USA, INC.
To: COVIS PHARMA GMBH
Reel/Frame 055363/0561 →
Release of Security Interest Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →